Comments on: UK Approves Novartis Eye Drug With A Twist http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/ News, Comment and Conversation Sat, 20 Mar 2010 00:23:22 +0000 http://wordpress.org/?v=2.6.2 By: elliottg http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/#comment-370456 elliottg Wed, 27 Aug 2008 17:42:52 +0000 http://www.pharmalot.com/?p=15193#comment-370456 Except Genentech didn't do that work. Only after the eye doctors did the work for them, did they reformulate the drug, threaten to cut off the cheaper supply and raise the price by 2 orders of magnitude. So if that's your argument, then the answer is Genentech and Novartis do NOT deserve the money. Except Genentech didn’t do that work. Only after the eye doctors did the work for them, did they reformulate the drug, threaten to cut off the cheaper supply and raise the price by 2 orders of magnitude. So if that’s your argument, then the answer is Genentech and Novartis do NOT deserve the money.

]]> By: Jack2 http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/#comment-370454 Jack2 Wed, 27 Aug 2008 17:23:35 +0000 http://www.pharmalot.com/?p=15193#comment-370454 The hard part of a drug design usually isn't the manufacturing. It's figuring out what the drug can treat, and then proving the drug treats that condition. Considering so many drugs don't make it, shouldn't companies make money when they do that? The hard part of a drug design usually isn’t the manufacturing. It’s figuring out what the drug can treat, and then proving the drug treats that condition. Considering so many drugs don’t make it, shouldn’t companies make money when they do that?

]]> By: elliottg http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/#comment-370451 elliottg Wed, 27 Aug 2008 17:01:04 +0000 http://www.pharmalot.com/?p=15193#comment-370451 oops. Avastin. oops. Avastin.

]]> By: elliottg http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/#comment-370440 elliottg Wed, 27 Aug 2008 16:04:17 +0000 http://www.pharmalot.com/?p=15193#comment-370440 What about Avantis? Novartis has some good PR people if they kept this aspect out of the story. The charge for Lucentis is extortion and is just a variation on the "your money or your life". Here it is "your money or your sight". What about Avantis? Novartis has some good PR people if they kept this aspect out of the story. The charge for Lucentis is extortion and is just a variation on the “your money or your life”. Here it is “your money or your sight”.

]]> By: Jack2 http://www.pharmalot.com/2008/08/uk-approves-novartis-eye-drug-with-a-twist/#comment-370424 Jack2 Wed, 27 Aug 2008 12:47:32 +0000 http://www.pharmalot.com/?p=15193#comment-370424 There may be something unique to the specifics of this cost-sharing agreement, but NICE and Pharma have already agreed to risk sharing agreements, where NICE only pays when the drug works (eg beta-interferons, cancer treatments). http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=507990&sk=&date=&%0A%09%09%09&pageID=2&searchString=Velcade%20NICE There may be something unique to the specifics of this cost-sharing agreement, but NICE and Pharma have already agreed to risk sharing agreements, where NICE only pays when the drug works (eg beta-interferons, cancer treatments).

http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=507990&sk=&date=&%0A%09%09%09&pageID=2&searchString=Velcade%20NICE

]]>